BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.05B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$801M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$384M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$339M |
| 5 |
Microsoft
MSFT
|
+$316M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$205M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
+$121M |
| 3 |
Thomson Reuters
TRI
|
+$106M |
| 4 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$100M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$96.1M |
Sector Composition
| 1 | Technology | 11.63% |
| 2 | Financials | 10.98% |
| 3 | Healthcare | 9.86% |
| 4 | Communication Services | 9.83% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
2776
DELISTED
Audentes Therapeutics, Inc
BOLD
| $37.6K | ﹤0.01% |
1,343
-271
| -17% | -$7.59K |
|
2777
Southern Missouri Bancorp
SMBC
$623M
| $37.4K | ﹤0.01% |
1,026
+401
| +64% | +$14.6K |
|
2778
Digimarc
DMRC
$224M
| $37.4K | ﹤0.01% |
1,022
-37
| -3% | -$1.35K |
|
|
OXFD
2779
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $37.4K | ﹤0.01% |
2,226
-155
| -7% | -$2.6K |
|
2780
Park-Ohio Holdings
PKOH
$313M
| $37.2K | ﹤0.01% |
816
-201
| -20% | -$9.17K |
|
2781
Lifecore Biomedical
LFCR
$288M
| $37K | ﹤0.01% |
2,854
-275
| -9% | -$3.56K |
|
2782
Natural Gas Services Group
NGS
$336M
| $36.9K | ﹤0.01% |
1,301
-96
| -7% | -$2.73K |
|
2783
Republic Bancorp
RBCAA
$1.47B
| $36.7K | ﹤0.01% |
944
-189
| -17% | -$7.35K |
|
2784
Chefs' Warehouse
CHEF
$2.75B
| $36.7K | ﹤0.01% |
1,902
-131
| -6% | -$2.53K |
|
2785
Carriage Services
CSV
$677M
| $36.7K | ﹤0.01% |
1,433
-152
| -10% | -$3.89K |
|
2786
Farmers National Banc Corp
FMNB
$553M
| $36.6K | ﹤0.01% |
2,434
-187
| -7% | -$2.81K |
|
2787
Intellia Therapeutics
NTLA
$1.33B
| $36.6K | ﹤0.01% |
1,472
-23
| -2% | -$572 |
|
2788
Okta
OKTA
$15.9B
| $36.4K | ﹤0.01% |
1,292
-80
| -6% | -$2.26K |
|
|
RCM
2789
DELISTED
R1 RCM Inc. Common Stock
RCM
| $36.4K | ﹤0.01% |
+9,821
| New | +$36.4K |
|
|
ZVO
2790
DELISTED
Zovio Inc. Common Stock
ZVO
| $36.4K | ﹤0.01% |
3,790
-772
| -17% | -$7.41K |
|
|
TPCO
2791
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $36K | ﹤0.01% |
2,480
-2,004
| -45% | -$29.1K |
|
2792
MidWestOne Financial Group
MOFG
$593M
| $36K | ﹤0.01% |
1,067
-57
| -5% | -$1.92K |
|
|
DS
2793
DELISTED
Drive Shack Inc.
DS
| $36K | ﹤0.01% |
9,967
-1,209
| -11% | -$4.37K |
|
|
CHCT
2794
Community Healthcare Trust
CHCT
$432M
| $35.9K | ﹤0.01% |
1,330
-80
| -6% | -$2.16K |
|
|
SFS
2795
DELISTED
Smart & Final Stores, Inc.
SFS
| $35.8K | ﹤0.01% |
4,557
+832
| +22% | +$6.53K |
|
2796
CNB Financial Corp
CCNE
$757M
| $35.7K | ﹤0.01% |
1,306
-284
| -18% | -$7.76K |
|
2797
Potbelly
PBPB
$515M
| $35.7K | ﹤0.01% |
2,875
-1,452
| -34% | -$18K |
|
|
EXA
2798
DELISTED
EXA Corporation
EXA
| $35.6K | ﹤0.01% |
1,473
-64
| -4% | -$1.55K |
|
2799
Tejon Ranch
TRC
$439M
| $35.6K | ﹤0.01% |
1,737
-104
| -6% | -$2.13K |
|
|
ADMS
2800
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $35.4K | ﹤0.01% |
1,673
-114
| -6% | -$2.41K |
|